北美分子诊断市场预测至 2030 年 - 区域分析 - 按疾病领域（肿瘤、传染病、基因检测、心脏病、免疫系统疾病等）、技术（聚合酶链式反应、等温核酸扩增技术、DNA 测序和下一代测序、DNA 微阵列、原位杂交等）、产品和服务（检测和试剂盒、仪器以及服务和软件）以及最终用户（医院和诊所、诊断实验室、研究和学术机构以及其他的）
No. of Pages: 125 | Report Code: TIPRE00026717 | Category: Life Sciences
No. of Pages: 125 | Report Code: TIPRE00026717 | Category: Life Sciences
北美分子诊断市场已细分为美国、加拿大和墨西哥。越来越多地采用技术先进的产品，研究和开发的增加。开发活动、大型医疗保健企业的存在以及分子诊断的使用不断增加是推动该地区分子诊断市场增长的关键因素。 2022年，美国在北美分子诊断市场中占据最大份额。
北美分子诊断市场细分为疾病领域、技术、产品和服务、最终用户和国家。
根据技术，北美分子诊断市场分为聚合酶链反应（PCR）、原位杂交、等温核酸扩增技术 (INAAT)、DNA 测序和下一代测序 (NGS)、DNA 微阵列等。聚合酶链式反应 (PCR) 领域在 2022 年占据北美分子诊断市场份额最大。聚合酶链式反应 (PCR) 进一步细分为 RT-PCR、qPCR、多重 PCR 等。
根据产品和服务，北美分子诊断市场分为检测和试剂盒、仪器、服务和软件。 2022 年，检测和试剂盒领域占据北美分子诊断市场最大份额。
根据最终用户，北美分子诊断市场分为诊断实验室、医院和诊所、研究和学术机构、和别的。到2022年，诊断实验室领域占据北美最大的分子诊断市场份额。
按国家划分，北美分子诊断市场分为美国、加拿大和墨西哥。 2022 年，美国将主导北美分子诊断市场。
雅培实验室、安捷伦科技公司、赛默飞世尔科技公司、F. Hoffmann-La Roche Ltd、Qiagen NV、bioMerieux SA、Illumina Inc、 Danaher、Siemens Healthineers AG、Novartis AG 和 TBG Diagnostics Limited 是北美分子诊断市场上的一些领先公司。
Strategic insights for North America Molecular Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 8,056.48 Million |
| Market Size by 2030 | US$ 20,740.38 Million |
| Global CAGR (2022 - 2030) | 12.5% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By 疾病领域
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Molecular Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Molecular Diagnostics Market is valued at US$ 8,056.48 Million in 2022, it is projected to reach US$ 20,740.38 Million by 2030.
As per our report North America Molecular Diagnostics Market, the market size is valued at US$ 8,056.48 Million in 2022, projecting it to reach US$ 20,740.38 Million by 2030. This translates to a CAGR of approximately 12.5% during the forecast period.
The North America Molecular Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Molecular Diagnostics Market report:
The North America Molecular Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Molecular Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Molecular Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Molecular Diagnostics Market
